SI
SI
discoversearch

Technology Stocks : MGNX -- MacroGenics
MGNX 17.05+1.0%4:00 PM EDTNews

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (46)8/3/2017 1:02:21 PM
From: Miljenko Zuanic  Read Replies (1) of 63
 
<I think it is worth waiting for the next year of data to come in before rationalizing the pipeline. If they haven't found something to prune by then, I'll get worried.>


The point is to do this ahead of P1 results (early), from competitive landscape and in-house toxicology/efficacy model.


Yes, at this point I think that their PD1 (0012) is outdated (from efficacy model standpoint), and they are still talking about combining IT with in-house candidates? HYPE!!!! OR true waste of the company source????


So, If they think that their bi-specific IO is OK, and from preclinical data one would think so,...why not push in this direction????


IF they can bring 50-50 partner (US, and WW right)...well.......
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.